Trial Profile
A Phase 1 Crossover Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of Two Formulations of a 7-Day Application Donepezil Transdermal Delivery System (TDS) Compared to Oral Administration of Aricept (Registered Trademark) in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Jul 2019
Price :
$35
*
At a glance
- Drugs Donepezil (Primary) ; Donepezil
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- Sponsors Corium International
- 28 Jul 2016 Status changed from recruiting to completed according to results presented at the Alzheimer's Association International Conference 2016.
- 20 Jul 2016 According to Corium International media release, results from this study will be presented at Alzheimer's Association International Conference 2016.
- 03 Feb 2016 Top-line interim results published in a Corium International media release.